CTI BIOPHARMA CORP's ticker is and the CUSIP is 12648L956. A total of 3 filers reported holding CTI BIOPHARMA CORP in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $0 | -100.0% | 300 | -92.7% | 0.00% | – |
| Q3 2015 | $6,000 | -53.8% | 4,100 | -37.9% | 0.00% | – |
| Q2 2015 | $13,000 | -78.3% | 6,600 | -79.9% | 0.00% | – |
| Q1 2015 | $60,000 | -17.8% | 32,900 | +6.8% | 0.00% | – |
| Q4 2014 | $73,000 | +508.3% | 30,800 | +528.6% | 0.00% | – |
| Q3 2014 | $12,000 | -61.3% | 4,900 | -55.5% | 0.00% | – |
| Q2 2014 | $31,000 | – | 11,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 256 | $62,000 | 0.00% |
| Citadel Advisors | 4,900 | $12,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 4,100 | $10,000 | 0.00% |